U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Johnson & Johnson

Market Cap: US$631.6b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Bristol-Myers Squibb

Market Cap: US$132.1b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Zoetis

Market Cap: US$31.3b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Amgen

Market Cap: US$225.9b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Pfizer

Market Cap: US$152.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Merck

Market Cap: US$334.4b

Operates as a healthcare company worldwide.

AbbVie

Market Cap: US$443.2b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Agilent Technologies

Market Cap: US$42.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Phibro Animal Health

Market Cap: US$1.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Gilead Sciences

Market Cap: US$171.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Qiagen

Market Cap: US$8.9b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Danaher

Market Cap: US$143.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Royalty Pharma

Market Cap: US$33.7b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Viatris

Market Cap: US$18.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

AnaptysBio

Market Cap: US$1.7b

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.

Hisamitsu Pharmaceutical

Market Cap: US$8.2b

Manufactures and sells pharmaceuticals in Japan.

GH Research

Market Cap: US$1.9b

Together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.

BioNTech

Market Cap: US$23.1b

Engages in the development and commercialization of immunotherapies in Germany.

Septerna

Market Cap: US$2.1b

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Dianthus Therapeutics

Market Cap: US$6.1b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Arcus Biosciences

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

Biogen

Market Cap: US$31.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

Exelixis

Market Cap: US$12.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Madrigal Pharmaceuticals

Market Cap: US$11.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Nurix Therapeutics

Market Cap: US$2.8b

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Trevi Therapeutics

Market Cap: US$2.6b

A clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

AtaiBeckley

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Alnylam Pharmaceuticals

Market Cap: US$30.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Tempus AI

Market Cap: US$9.8b

Operates as a healthcare technology company in the United States.

ADMA Biologics

Market Cap: US$2.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Adaptive Biotechnologies

Market Cap: US$3.9b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Kodiak Sciences

Market Cap: US$2.5b

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Vaxcyte

Market Cap: US$8.8b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Organon

Market Cap: US$3.6b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.